{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:23:52Z","timestamp":1747167832997,"version":"3.40.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.msard.2024.105745","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T17:20:55Z","timestamp":1719422455000},"page":"105745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1869-7067","authenticated-orcid":false,"given":"Alice","family":"Mariottini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily H.","family":"Stack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govind","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Nozzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Boncompagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Repice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Fainardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Di","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Carlesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Saccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Massacesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10044","key":"10.1016\/j.msard.2024.105745_bib0009","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","article-title":"Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial","volume":"388","author":"Atkins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2024.105745_bib0026","series-title":"Clinical Neurovirology","first-page":"177","article-title":"Human T lymphotropic virus type 1 (HTLV-1)","author":"Azodi","year":"2020"},{"issue":"2","key":"10.1016\/j.msard.2024.105745_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.26281","article-title":"Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis","volume":"91","author":"Bischof","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105745_bib0032","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000011461","article-title":"Long-term clinical outcomes of hematopoietic stem cell transplantation in multiple sclerosis","author":"Boffa","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0008","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00415-021-10820-2","article-title":"Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis","volume":"269","author":"Burt","year":"2022","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105745_bib0017","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jon.12553","article-title":"Spinal Cord Atrophy in Multiple Sclerosis: a Systematic Review and Meta-Analysis","volume":"28","author":"Casserly","year":"2018","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.msard.2024.105745_bib0005","article-title":"Immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis: a review on behalf of the EBMT autoimmune diseases working party","volume":"12","author":"Cencioni","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2024.105745_bib0042","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13760-021-01595-4","article-title":"The course of cervical spinal cord atrophy rate and its relationship with NEDA in relapsing remitting multiple sclerosis","volume":"122","author":"Cilingir","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2019.02.014","article-title":"Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the american society for blood and marrow transplantation","volume":"25","author":"Cohen","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.msard.2024.105745_bib0040","first-page":"93","article-title":"Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis","volume":"87","author":"De Stefano","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2024.105745_bib0036","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaneurol.2022.4156","article-title":"Time to change the current clinical classification of multiple sclerosis?","volume":"80","author":"Granziera","year":"2023","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105745_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/13524585211020296","article-title":"Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: a multiparametric MRI study","volume":"28","author":"Hidalgo de la Cruz","year":"2022","journal-title":"Multiple Sclerosis Journal"},{"issue":"10","key":"10.1016\/j.msard.2024.105745_bib0029","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1352458515616701","article-title":"Inclusion of brain volume loss in a revised measure of \u2018no evidence of disease activity\u2019(NEDA-4) in relapsing\u2013remitting multiple sclerosis","volume":"22","author":"Kappos","year":"2016","journal-title":"Multiple Scler. J."},{"key":"10.1016\/j.msard.2024.105745_bib0041","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00586-012-2176-4","article-title":"Normal morphology, age-related changes and abnormal findings of the cervical spine. Part II: magnetic resonance imaging of over 1,200 asymptomatic subjects","volume":"21","author":"Kato","year":"2012","journal-title":"Eur. Spine J."},{"issue":"12","key":"10.1016\/j.msard.2024.105745_bib0033","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1177\/1352458514521517","article-title":"Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis","volume":"20","author":"Katz Sand","year":"2014","journal-title":"Multiple Sclerosis J."},{"issue":"11","key":"10.1016\/j.msard.2024.105745_bib0015","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2024.105745_bib0039","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/1352458517715811","article-title":"Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis","volume":"24","author":"Lee","year":"2018","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2024.105745_bib0019","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jnnp-2014-308021","article-title":"Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis","volume":"86","author":"Lukas","year":"2015","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.msard.2024.105745_bib0006","doi-asserted-by":"crossref","DOI":"10.1007\/s40259-020-00414-1","article-title":"Haematopoietic stem cell transplantation for multiple sclerosis: current status","author":"Mariottini","year":"2020","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.msard.2024.105745_bib0013","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ene.15280","article-title":"Autologous haematopoietic stem cell transplantation versus low\u2010dose immunosuppression in secondary\u2013progressive multiple sclerosis","volume":"29","author":"Mariottini","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105745_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.820256","article-title":"Intermediate-intensity autologous hematopoietic stem cell transplantation reduces serum neurofilament light chains and brain atrophy in aggressive multiple sclerosis","volume":"13","author":"Mariottini","year":"2022","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.msard.2024.105745_bib0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105745_bib0025","article-title":"Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: quantification and correlation with clinical disability","volume":"30","author":"Mina","year":"2021","journal-title":"NeuroImage: Clinical"},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0031","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jnnp-2018-319446","article-title":"Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis","volume":"90","author":"Moore","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0004","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","article-title":"Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients","volume":"201","author":"Muraro","year":"2005","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.msard.2024.105745_bib0012","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","article-title":"Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"74","author":"Muraro","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.msard.2024.105745_bib0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrneurol.2017.81","article-title":"Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis","volume":"13","author":"Muraro","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2024.105745_bib0022","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \"McDonald Criteria\"","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2024.105745_bib0023","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.105745_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105745_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.2005.063883","article-title":"Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis","volume":"77","author":"Samijn","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"14","key":"10.1016\/j.msard.2024.105745_bib0038","first-page":"P60","article-title":"Spinal Cord lesions and relationship to spinal cord atrophy and disability in multiple sclerosis (P60.168)","volume":"84","author":"Seraji-Bozorgzad","year":"2015","journal-title":"Neurology"},{"journal-title":"Bone Marrow Transplant.","year":"2019","author":"Sharrack","key":"10.1016\/j.msard.2024.105745_bib0003"},{"issue":"1","key":"10.1016\/j.msard.2024.105745_bib0027","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nimg.2002.1040","article-title":"Accurate, robust, and automated longitudinal and cross-sectional brain change analysis","volume":"17","author":"Smith","year":"2002","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.msard.2024.105745_bib0028","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.neuroimage.2004.07.051","article-title":"Advances in functional and structural MR image analysis and implementation as FSL","volume":"23","author":"Smith","year":"2004","journal-title":"Neuroimage"},{"issue":"10130","key":"10.1016\/j.msard.2024.105745_bib0001","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0011","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/ane.13147","article-title":"Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation","volume":"140","author":"Tolf","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2024.105745_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuroscience.2017.07.055","article-title":"Neuroimaging Techniques to Assess Inflammation in Multiple Sclerosis","volume":"403","author":"Tommasin","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.msard.2024.105745_bib0018","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1212\/WNL.0000000000005853","article-title":"Spinal cord volume loss: a marker of disease progression in multiple sclerosis","volume":"91","author":"Tsagkas","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2024.105745_bib0034","first-page":"342","article-title":"Multiple sclerosis phenotypes as a continuum: the role of neurologic reserve","volume":"11","author":"Vollmer","year":"2021","journal-title":"Neurology: Clinical Practice"},{"issue":"5","key":"10.1016\/j.msard.2024.105745_bib0037","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/ana.26341","article-title":"Spinal cord atrophy is a preclinical marker of progressive MS","volume":"91","author":"Zeydan","year":"2022","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2024.105745_bib0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14737175.2016.1181543","article-title":"Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine","volume":"16","author":"Zivadinov","year":"2016","journal-title":"Expert. Rev. Neurother."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:52:30Z","timestamp":1728399150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"alternative-id":["S2211034824003225"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105745","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105745"}}